Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.5 GBX | -.--% | +3.92% | +52.30% |
May. 28 | Sirius Real Estate Non-Exec Director James Peggie to resign | AN |
May. 24 | Michael Ashcroft ups stake in Marlowe to 16% | AN |
Sales 2023 | 23.7M 30.19M | Sales 2024 * | 29.61M 37.72M | Capitalization | 112M 143M |
---|---|---|---|---|---|
Net income 2023 | -1M -1.27M | Net income 2024 * | -2M -2.55M | EV / Sales 2023 | 3.09 x |
Net cash position 2023 * | 16.03M 20.42M | Net cash position 2024 * | 13.67M 17.42M | EV / Sales 2024 * | 3.32 x |
P/E ratio 2023 |
-42
x | P/E ratio 2024 * |
-63.9
x | Employees | 151 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 65.42% |
Latest transcript on Diaceutics PLC
1 week | +3.92% | ||
1 month | +33.84% | ||
3 months | +38.02% | ||
6 months | +43.24% | ||
Current year | +52.30% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Keeling
CEO | Chief Executive Officer | 40 | 08-05-31 |
Nick Roberts
DFI | Director of Finance/CFO | - | 22-03-17 |
Julie Browne
COO | Chief Operating Officer | - | 22-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Paterson
BRD | Director/Board Member | - | 23-09-30 |
Deborah Davis
CHM | Chairman | 61 | 21-01-03 |
Peter Keeling
BRD | Director/Board Member | 63 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 132.5 | -.--% | 138,698 |
24-05-30 | 132.5 | -0.38% | 422,322 |
24-05-29 | 133 | +3.91% | 452,035 |
24-05-28 | 128 | +0.39% | 13,373 |
24-05-24 | 127.5 | -.--% | 37,366 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.30% | 142M | |
+15.68% | 4.44B | |
-19.34% | 2.29B | |
+31.16% | 2.05B | |
-12.17% | 1.55B | |
-2.54% | 1.53B | |
-23.03% | 1.46B | |
-11.45% | 1.12B | |
-35.74% | 1.14B | |
-7.12% | 1.02B |
- Stock Market
- Equities
- DXRX Stock